GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) » Definitions » Gross Profit

Torrent Pharmaceuticals (NSE:TORNTPHARM) Gross Profit : ₹75,150 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Torrent Pharmaceuticals Gross Profit?

Torrent Pharmaceuticals's gross profit for the three months ended in Dec. 2023 was ₹19,940 Mil. Torrent Pharmaceuticals's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was ₹75,150 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Torrent Pharmaceuticals's gross profit for the three months ended in Dec. 2023 was ₹19,940 Mil. Torrent Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹26,910 Mil. Therefore, Torrent Pharmaceuticals's Gross Margin % for the quarter that ended in Dec. 2023 was 74.10%.

Torrent Pharmaceuticals had a gross margin of 74.10% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Torrent Pharmaceuticals was 74.70%. The lowest was 66.70%. And the median was 69.68%.


Torrent Pharmaceuticals Gross Profit Historical Data

The historical data trend for Torrent Pharmaceuticals's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals Gross Profit Chart

Torrent Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51,401.70 55,274.90 56,509.30 58,813.30 66,360.00

Torrent Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,290.00 16,550.00 18,980.00 19,680.00 19,940.00

Competitive Comparison of Torrent Pharmaceuticals's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Gross Profit falls into.



Torrent Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Torrent Pharmaceuticals's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=94636.9 - 28276.9
=66,360

Torrent Pharmaceuticals's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=26910 - 6970
=19,940

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹75,150 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Torrent Pharmaceuticals's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=19,940 / 26910
=74.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Torrent Pharmaceuticals  (NSE:TORNTPHARM) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Torrent Pharmaceuticals had a gross margin of 74.10% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Torrent Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of Torrent Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Torrent Pharmaceuticals (NSE:TORNTPHARM) Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through Generic Formulation Business segments. Geographically, the business activities are carried out across Indian and International markets.

Torrent Pharmaceuticals (NSE:TORNTPHARM) Headlines

No Headlines